News
HC Wainwright & Co. Reiterates Buy on MoonLake, Maintains $100 Price Target
11 Apr 24
News, Price Target, Reiteration, Analyst Ratings
Needham Reiterates Buy on MoonLake, Maintains $66 Price Target
9 Apr 24
News, Price Target, Reiteration, Analyst Ratings
Goldman Sachs Initiates Coverage On MoonLake with Neutral Rating, Announces Price Target of $62
2 Apr 24
News, Price Target, Initiation, Analyst Ratings
Wedbush Reiterates Outperform on MoonLake, Maintains $92 Price Target
13 Mar 24
News, Price Target, Reiteration, Analyst Ratings
Why Is Inflammatory Disease-Focused MoonLake Immunotherapeutics Stock Trading Higher Today?
11 Mar 24
Biotech, Equities, News, Health Care, Movers, Trading Ideas, General
Wedbush Reiterates Outperform on MoonLake, Maintains $92 Price Target
11 Mar 24
News, Price Target, Reiteration, Analyst Ratings
HC Wainwright & Co. Maintains Buy on MoonLake, Raises Price Target to $100
11 Mar 24
News, Price Target, Analyst Ratings
Needham Reiterates Buy on MoonLake, Maintains $66 Price Target
11 Mar 24
News, Price Target, Reiteration, Analyst Ratings
HC Wainwright & Co. Reiterates Buy on MoonLake, Maintains $75 Price Target
4 Mar 24
News, Price Target, Reiteration, Analyst Ratings
Cooper Companies Reports Upbeat Results, Joins Dell, NetApp, Tidewater And Other Big Stocks Moving Higher On Friday
1 Mar 24
News, Small Cap, Intraday Update, Markets, Movers, Trading Ideas
Wedbush Reiterates Outperform on MoonLake, Maintains $92 Price Target
1 Mar 24
News, Price Target, Reiteration, Analyst Ratings
Needham Reiterates Buy on MoonLake, Maintains $66 Price Target
1 Mar 24
News, Price Target, Reiteration, Analyst Ratings
MoonLake Immunotherapeutics Announces FDA And EMA Feedback For Regulatory Path For Phase 3 Program Of Nanobody Sonelokimab In Hidradenitis Suppurativa
26 Feb 24
Biotech, News, FDA, General
Wolfe Research Initiates Coverage On MoonLake with Outperform Rating
15 Feb 24
News, Initiation, Analyst Ratings
Press releases
MoonLake Immunotherapeutics Inks Three-Year Technology Partnership With Komodo Health To Advance Research on Inflammatory Skin and Joint Conditions
10 Apr 24
Press Releases
MoonLake announces significant improvements with Nanobody® sonelokimab over 24 weeks in active psoriatic arthritis (PsA) and other important updates at its R&D Day
10 Mar 24
Press Releases